Neonatal Respiratory Distress Syndrome Clinical Trial
Official title:
Flow-cycled Ventilation in Preterm Infants (FLIPI): A Pilot Study Looking at the Tolerance of Flow-cycled Ventilation by Preterm Infants With Respiratory Distress Syndrome
This short pilot study is to assess the tolerance of preterm infants, born below 32 weeks
gestation with respiratory distress syndrome, to flow-cycle ventilation, and see if infants
require less overall pressure from the ventilator than the usual conventional settings used,
with the aim of providing data to construct a larger trial looking at the longer term outcome
of these infants using this type of ventilation in the future.
Many preterm infants at these gestations require assistance from a ventilator due to the
immaturity of their lungs. The lungs of preterm infants are susceptible to damage, especially
if high pressures are needed or prolonged periods of ventilation. There is concern that if
the infant's breathing pattern does not synchronise with the ventilator, this causes
additional distress, longer duration of ventilation needed and increased risk of
complications. Over the past 20 years, a different type of ventilation, known as flow-cycle
ventilation, has been trialed, with limited use in preterm infants. This allows the baby to
determine the duration of breathing in and out and how many breaths they require per minute.
This would help babies to synchronise better with the ventilator, and consequently require
less pressure from the ventilator.
This pilot study is being conducted at St. Mary's Hospital, Manchester. All babies born under
32 weeks gestation, with a stable respiratory effort, will be eligible for consideration for
the study. The study will last no longer than 5 hours and involve the babies receiving
different pressures from the ventilator in flow-cycle mode for 1-hour epochs. Blood gases
after each epoch and continuous ventilator data will be downloaded to assess their tolerance
on the different settings, before being returned to the usual conventional settings used on
the unit. The babies will have continuous monitoring throughout as per standard neonatal
intensive care.
This study will be conducted as a short term, crossover study, where each infant will act as
his or her own control and undertake all interventions within this study. The study is broken
down into two parts in order to answer the two secondary research questions.
The limited studies looking at flow-cycled ventilation in preterm babies have been set up in
a similar manner. Making each infant its own control limits the number of infants needed for
this pilot study.
1. Prior preparations regarding protocol design
The protocol has already been reviewed by the University of Leeds, by paper submission
and viva to determine the suitability of the project from an educational point of view
and suitability for the restricted time frame and resources available. Discussions with
the neonatal unit technical support staff have already been undertaken to ensure that
the study ventilators (an exact model to that used on the unit, but mobile) are
configured with the required backup ventilation mode, to maintain the required level of
breathing support, safety alarms and settings checked and the Eview box (device which
allows the collection of data about the baby from the ventilator) installed as per
manufacture guidelines.
Training has also been given to the Principal investigator on the setup and maintenance
of the study ventilator (the principal investigator is also a member of the clinical
team who uses these ventilators on a daily basis and aware of how they are used).
2. Prior clinical care given & assessment for eligibility
Prior to the study, eligible babies would have had a breathing tube inserted and
surfactant medication given due to concerns with underdeveloped / immature lungs,
fitting with being born at an early gestation. They would be receiving breathing support
from the Engstrom Carestation Version 5.X (GE Healthcare) ventilator, the same
ventilator used for the study, and would have received a dose of caffeine citrate
intravenously to aid the infant's breathing drive, in line with unit policy and
international consensus on managing respiratory distress syndrome in preterm infants.
The clinical team may have deemed it necessary for monitoring and blood sampling to have
inserted a catheter into one of the infant's arteries (an arterial line), though this is
not a requisite for the study, but would be used for monitoring and sampling during the
study if the infant was suitable. As per routine practice, the infants will have two
methods of monitoring at all times. This would monitor oxygen saturations and heart rate
as well as having monitoring on for blood pressure, breathing rate and temperature where
deemed necessary.
As both of the Principal and Chief Investigators are members of the clinical team on the
neonatal intensive care unit at St. Mary's Hospital, it is easy to highlight suitable
infants for the study from the patient lists and admissions to the unit, though prior
discussion will take place with the attending neonatal team to discuss suitability. For
any infant deemed potentially suitable after discussion with the attending clinical
team, a parent information leaflet will be given to the parents at the time of greeting
& introducing the study, after they have received an update on their baby's progress to
date. As much time as possible will be allowed between this introduction and any attempt
to answer questions and obtain written consent (minimum one hour) to allow the parents
uncoerced thinking time.
During this time, the research team will corroborate with the attending nurse /
clinician and review the clinical data on the infant, including the x-rays done up until
this time, the nursing observations and blood gas results, in order to assess for the
inclusion and exclusion criteria. An eligibility form will be completed and signed by
both a member of the research team and clinical team to ensure an agreement of
eligibility. If there are concerns, the infant will not be recruited at this time.
At an appropriate time for the parents, they will be approached by the Principal or
Chief Investigator and any questions answered about the study. The research team will
have to be happy that the parents have understood the information, implications,
alternatives and are free to make a choice (as well as being eligible to consent
legally). If the infant is suitable, a consent form will be completed. Randomisation
will then occur by taking a sealed study envelope from the study box to find out which
order they will undertake the different parts of the trial, and will be allocated a
study number, which will be used on all documentation pertaining to the study, to ensure
anonymity. (The study box would already have been pre-made with sealed envelopes
containing information that has been generated from a random number database. The
process of randomisation prevents there from being any influence on the final results
purely due to the order in which the study parts are undertaken, making the study more
robust to analyse. This has been a previous concern with other studies in the
literature).
The study ventilator (an exact model of the ventilator used on the unit) will be set up
and safety checks undertaken, as well as the Eview box (the box which allows the
ventilator data to be extracted and analysed though has no interference with the working
of the ventilator itself) installed, safety back-up modes enabled to ensure that the
infant has sufficient breathing support from the ventilator in the event that they do
not maintain a strong breathing pattern, and the study number and weight of the child be
accurately entered into the ventilator by the research team.
The researcher will then examine the infant to ensure that the time of commencing the
study the infant still satisfies the criteria for inclusion and is deemed 'stable' and a
blood gas sample will be taken from the baby (either from the pre-sited arterial line if
available or from the capillaries in the foot according to standard practice; distress
and amount of blood will be minimised and should not cause any instability). This sample
will be analysed by the machines routinely used on the intensive care unit, and any
other blood tests that the infant may need (e.g. blood sugar monitoring, which is
usually done every 2-4 hours at this stage) will be performed at the same time / on the
same sample of blood (if possible) to minimise distress and interventions. A special
nursing observation chart will be commenced at this time by the attending nurse /
research team, recording the routine observations that any ventilated infant would
require. This first set of observations (on the pre-study ventilator settings) would be
the baseline settings, allowing any deviation from this stability to be highlighted and
acted upon early.
3. First part of study
The infant would be switched onto the study ventilator, a process which takes less than
a second, and involves disconnecting the old ventilator tubing from the breathing tube
reconnecting it to the new ventilator tubing. This is necessary in order for Eview box
to work (the original ventilator would have to be turned off for a short period of time,
which would not be ethical to leave the baby without controlled breathing support). Care
would be taken not to dislodge the breathing tube whilst the infant was examined to
ensure that the chest was rising and that the ventilator was receiving data from the
infant. The time on the ventilator would be noted down on the observation chart to aid
with data analysis later.
Depending on randomisation, the infant would either receive a high pressure or low
pressure from the study ventilator.
- All other settings would match those that the infant was on beforehand where
possible. (The high and low pressures are pre-set based on what pressure the infant
was requiring before the study with either 80% of this (low pressure) or 120% of
this (high pressure) these limits are deemed to be safe and within acceptable
clinical practice).
- The infant would remain on this setting for 1 hour.
- Their nursing observations will be recorded every 15 minutes, including a blood
pressure if they did not have an arterial line to read it continuously (this is not
unusual practice as the baby would receive this intensity of observation if they
were having a blood transfusion).
After the end of the hour, a blood gas would be taken, and the ventilator would be
switched to the other setting (either low pressure, if the infant previously received
high pressure, or vice versa). The same process would be repeated in terms of the
timings and observations taken. The time on the ventilator would be noted for analysis
purposes when the pressures were switched.
After the second hour, the blood gas would be repeated and the infant placed back on the
initial ventilator, on a setting appropriate for the condition of the infant at that
time. This completes the first part of the study and the infant would resumed routine
care for a least an hour. A blood gas would be taken after 1 hour as per usual
convention to ensure that they are stable and settled back onto the initial ventilator.
4. Second part of the study
After 1 hour back on the standard ventilator, the infant would be reassessed to ensure
that they were stable. If this is the case, as stated above, a blood gas would be taken
and part two of the study commenced. The observations recorded would provide a baseline
for the second part of the study. The infant would once again be switched back to the
study ventilator and time noted.
Depending on the initial randomisation, the infant would either receive time-cycled
ventilation (the usual convention) or flow-cycled ventilation (as in part one of the
study) from the study ventilator.
- All other settings would match those that the infant was on beforehand where
possible.
- The infant would remain on this setting for 1 hour.
- Their nursing observations will be recorded every 15 minutes, including a blood
pressure if they did not have an arterial line to read it continuously.
After the end of the hour, a blood gas would be taken, and the ventilator would be
switched to the other setting (either flow-cycled, if the infant previously received
time-cycled, or vice versa). The same process would be repeated in terms of the timings
and observations taken.
The time on the ventilator would be noted for analysis purposes when the pressures were
switched.
After the second hour, the blood gas would be repeated and the infant placed back on the
initial ventilator, on a setting appropriate for the condition of the infant at that
time. This completes the second and final part of the study and the infant would resume
routine care for the duration of their stay on the unit. A blood gas would be taken
after 1 hour as per usual convention to ensure that they are stable and settled back
onto the initial ventilator.
5. After completion of study
After the study had been completed, there would be a handover of care back to the
attending clinical team with update to the clinical team and parents (if present)
regarding the clinical condition of the baby.
Regarding the data, the encrypted flash disk will be removed from the study ventilator
and the data downloaded on an NHS computer on the unit. This data, along with the
nursing observation charts and blood gas results, will then be reviewed by the
independent consultant neonatologist for safety and quality assurance prior to a second
baby undergoing the study.
The researcher is responsible for ensuring that the study ventilator is cleaned
appropriately in line with the manufactures and unit guidelines and is ready for any
future participants.
6. Safety interventions
These have been highlighted in the main issues question where there is a break from protocol
due to safety concerns. It is clear in the protocol what needs to be done if there are
concerns. Only one baby will undergo the study at any one time and any concerns will be
reviewed by the researchers.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT04019886 -
Impact of Neurophysiological Facilitation of Respiration in Preterm Neonates
|
N/A | |
| Terminated |
NCT02999165 -
Breastfeeding Infants Receiving Respiratory Support Trial
|
||
| Completed |
NCT02112513 -
The Use of Maternal Serum Unconjugated Estriol for Monitoring the Prevention of Neonatal Respiratory Distress Syndrome
|
||
| Completed |
NCT02824497 -
Early Neonatal Respiratory Distress: Changes in Level IIb Hospital Over a Period of One Year
|
||
| Completed |
NCT04000568 -
Breathing Variability and NAVA in Neonates
|
||
| Completed |
NCT01926106 -
Nasal Intermittent Positive-Pressure Ventilation for Twin Infants With Respiratory Distress Syndrome
|
N/A | |
| Completed |
NCT02819050 -
Effective Approaches & Strategies to Ease Off Nasal CPAP In Preterm Infants
|
N/A | |
| Completed |
NCT02041676 -
Chest Physiotherapy Technique Increasing Inspiratory Flow on Weaning From Non Invasive Ventilation
|
N/A | |
| Completed |
NCT02333669 -
Association of SCNN1A Single Nucleotide Polymorphisms With Neonatal Respiratory Distress Syndrome
|
N/A | |
| Recruiting |
NCT04409665 -
The Use of Sedation Drugs in the Procedure of Administering Surfactant Without Intubation (LISA/MIST)
|
Phase 1 | |
| Completed |
NCT03446937 -
Effect of Antenatal Corticosteroids on Neonatal Morbidity.
|
N/A | |
| Terminated |
NCT03235986 -
A Study To InvestigateThe Safety, Tolerability And Efficacy Of Nebulised Curosurf® In Preterm Neonates With Respiratory Distress Syndrome (RDS)
|
Phase 2 | |
| Recruiting |
NCT06367881 -
Assessment Of Dose-Dependent Immunomodulatory Effect Of Alveofact With or Without Steroisd In Neonatal RDS
|
Phase 1 |